biguanides has been researched along with Endophthalmitis in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ristau, T | 1 |
| Kirchhof, B | 1 |
| Fauser, S | 1 |
1 other study available for biguanides and Endophthalmitis
| Article | Year |
|---|---|
Antisepsis with polyhexanide is effective against endophthalmitis after intravitreal injections.
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Antisepsis; Biguanides; Endophthalmitis; Eye Infecti | 2014 |